Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThere are no significant changes between the old and new screenshots; the Study Details page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check44 days agoChange DetectedThe page now highlights Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior revision (v3.0.2), indicating a shift in content scope toward versioning rather than the previously listed safety topics.SummaryDifference0.4%

- Check58 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, pricing, or availability.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to drug safety and various medical conditions. Notably, several specific drug categories and terms have been removed.SummaryDifference3%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.